on Leon-nanodrugs GmbH
Leon-nanodrugs Appoints Dr. Wolfgang Hofmann as CEO Amid Market Expansion
Munich-based leon-nanodrugs GmbH announces the appointment of Dr. Wolfgang Hofmann as its new Chief Executive Officer. This strategic move comes as the company transitions from development to commercialization of its FR-JET® technology and equipment portfolio. Dr. Hofmann, with three decades of experience, is expected to steer the company through growth, focusing on establishing partnerships and expanding manufacturing capabilities.
Dr. Hofmann's career includes pivotal roles at Dana-Farber Cancer Institute, Harvard Medical School, and senior positions at Novartis and Fresenius Group. He is confident in the potential of LEON’s systems to revolutionize the manufacturing of nanoparticles in terms of quality and cost efficiency. Dr. Hubert Birner, Supervisory Board Chairman, highlights Hofmann's skills as vital for shaping LEON's strategic direction and global outreach.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Leon-nanodrugs GmbH news